PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
31-Mar-2023 MediClin AG: Group sales and Group operating result above previous year − cautious outlook for 2023 MediClin AG
31-Mar-2023 LEADING MICROBIOLOGY TESTING FACILITY INVESTS IN THE FUTURE Wickham Micro
31-Mar-2023 Almirall: The New England Journal of Medicine (NEJM) and the British Journal of Dermatology (BJD) publish Ph3 data evaluating lebrikizumab efficacy and safety in moderate-to-severe atopic dermatitis Almirall
31-Mar-2023 HUTCHMED Completes Rolling Submission of NDA to U.S. FDA for Fruquintinib for the Treatment of Refractory Metastatic Colorectal Cancer HUTCHMED
31-Mar-2023 BioSenic provides financial update and financial calendar 2023 BioSenic
31-Mar-2023 Call for urgency to deliver on global pledge for antibiotic incentives ABPI
31-Mar-2023 Sartorius Stedim Biotech SA: Sartorius Stedim Biotech to acquire Polyplus Sartorius Stedim Biotech SA
31-Mar-2023 Lonza Launches Share Buyback Program of up to CHF 2 Billion Lonza Group AG
31-Mar-2023 AEVIS VICTORIA SA – Publication of the Annual Report 2022 AEVIS VICTORIA SA
31-Mar-2023 Modern Dental Group Announces 2022 Annual Results - Recorded the Second Highest Net Profit of HK$221 million and Built a Comprehensive Dental Ecosystem with High-quality Development Modern Dental Group Limited
30-Mar-2023 Biophytis: The Combined General Meeting will be held on second call on April 17, 2023 Biophytis
30-Mar-2023 Clinical Study of TISSIUM’s COAPTIUM Connect Atraumatic Sutureless Nerve Coaptation System Is Underway in Australia TISSIUM
30-Mar-2023 Modus Therapeutics secures access to bridge financing from longstanding investor Karolinska Development Modus Therapeutics
30-Mar-2023 AlzeCure presents new data at Alzheimer’s conference AD/PD on the potential disease-modifying effect of NeuroRestore ACD856 AlzeCure
30-Mar-2023 Immutep announces expansion of triple combination therapy in first-line non-small cell lung cancer Immutep
30-Mar-2023 AskBio to Present Phase 1b Results Investigating AB-1005 (formerly AAV2-GDNF) as Treatment for Parkinson’s Disease at AD/PDTM 2023 International Conference on Alzheimer's and Parkinson's Diseases Asklepios BioPharmaceutical, Inc
30-Mar-2023 Théa Open Innovation and Galimedix announce strategic partnership to develop and commercialize GAL-101, a Phase 2/3-ready small molecule, to treat ophthalmic indications with high unmet medical need Galimedix Therapeutics
30-Mar-2023 Evonik underpins leading position in drug delivery for RNA therapeutics with start of construction of new U.S. facility for pharmaceutical lipids Evonik
30-Mar-2023 NRG Therapeutics Announces International Scientific Advisory Board NRG Therapeutics
30-Mar-2023 Trobix Bio Raises $3 Million from Chartered Group to Advance Precision Microbiome Oncology Therapeutics Trobix Bio